【摘要】 目的 總結(jié)膀胱小細(xì)胞癌的診斷及治療。 方法 2009年8月1例行根治性膀胱切除、回腸代膀胱術(shù)患者經(jīng)病理學(xué)、免疫組織化學(xué)檢查確診為膀胱小細(xì)胞癌?;颊呓邮蹺P治療方案治療。 結(jié)果 治療4周期后,復(fù)查CT未見轉(zhuǎn)移,無Ⅲ~Ⅳ級毒副反應(yīng)。 結(jié)論 膀胱小細(xì)胞癌需依靠病理學(xué)及免疫組織化學(xué)檢查確診,治療目前參考小細(xì)胞肺癌治療方案,以化學(xué)療法為主,復(fù)習(xí)文獻(xiàn)得出有無手術(shù)切除并不影響膀胱小細(xì)胞癌患者的預(yù)后,靶向藥物的治療尚需進(jìn)一步研究。
引用本文: 何建萍,劉繼彥,易成,畢鋒,許峰. 膀胱小細(xì)胞癌一例. 華西醫(yī)學(xué), 2011, 26(2): 246-247. doi: 復(fù)制
1. | Cramer SF, Aikawa M, Cebelin M. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder[J]. Cancer, 1981, 47(4): 724-30. |
2. | Selli C, Gelmini S, Scott CA, et al. Evidence for elevated telomerase activity in small cell carcinoma of the bladder[J]. Urology, 2000, 56 (2): 331. |
3. | Holmang S, Borghede G, Johansson SL. Primary small cell car- cinoma of the bladder:a report of 25 cases[J]. J Urol, 1995, 153(6): 1820-1822. |
4. | Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients[J]. Cancer, 2004, 101(5): 957-962. |
5. | Abrahams NA, Moran C, Reyes AO, et al. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases[J]. Histopathology, 2005, 46(1): 57-63. |
6. | 曹志彬. 膀胱小細(xì)胞癌: 一種罕見的膀胱癌[J]. 國際泌尿系統(tǒng)雜志, 2006, 26(1): 25-28. |
7. | Bastús R, Caballero JM, González G, et al. Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: resul tsin five cases[J]. Eur Urol, 1999, 35(4): 323-326. |
8. | Grignon DJ, Ro JY, Ayala AG, et al. Small cell car-cinoma of the urinary bladder. A clinicopathologic analysis of 22 cases[J]. Cancer, 1992, 69(2): 527-536. |
9. | 潘進(jìn)勇, 王曉維. 膀胱小細(xì)胞癌的研究進(jìn)展[J]. 中華腫瘤防治雜志, 2007, 6(14): 864-865. |
10. | Abbas F, Civantos F, Benedetto P, et al. Small cell carcinoma of the bladder and prostate[J]. Urology, 1995, 6(5): 617-630. |
11. | Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience[J]. Cancer, 2005, 103(6): 1172-1178. |
12. | Dreicer R, Manola J, Roth BJ, et al. Phase Ⅱ study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study[J]. J Clin Oncol, 2000, 18(5): 1058-1061. |
13. | Bajorin DF, McCafrey JA, Dodd PM, et al. Ifosfamide, paclitaxel, and cisplatin for patients witll advanced transitional cell carcinoma of the urothelial tract: final report of a phase Ⅱ trial evaluating two dosing schedules[J]. Cancer, 2000, 88(7): 1671-1678. |
14. | Pan CX, Yang XJ, Lopez-Behran A, et al. c-kit-Expression in small cell carcinoma of the urinary bladder: prognostic and therapo utic implications[J]. Mod Pathol, 2005, 18(3): 320-323. |
15. | 程亮, 黃文斌, 陳杰. 膀胱小細(xì)胞癌臨床病理學(xué)和分子遺傳學(xué)研究進(jìn)展[J]. 中華病理學(xué)雜志, 2007, 36(10): 700-702. |
- 1. Cramer SF, Aikawa M, Cebelin M. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder[J]. Cancer, 1981, 47(4): 724-30.
- 2. Selli C, Gelmini S, Scott CA, et al. Evidence for elevated telomerase activity in small cell carcinoma of the bladder[J]. Urology, 2000, 56 (2): 331.
- 3. Holmang S, Borghede G, Johansson SL. Primary small cell car- cinoma of the bladder:a report of 25 cases[J]. J Urol, 1995, 153(6): 1820-1822.
- 4. Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients[J]. Cancer, 2004, 101(5): 957-962.
- 5. Abrahams NA, Moran C, Reyes AO, et al. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases[J]. Histopathology, 2005, 46(1): 57-63.
- 6. 曹志彬. 膀胱小細(xì)胞癌: 一種罕見的膀胱癌[J]. 國際泌尿系統(tǒng)雜志, 2006, 26(1): 25-28.
- 7. Bastús R, Caballero JM, González G, et al. Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: resul tsin five cases[J]. Eur Urol, 1999, 35(4): 323-326.
- 8. Grignon DJ, Ro JY, Ayala AG, et al. Small cell car-cinoma of the urinary bladder. A clinicopathologic analysis of 22 cases[J]. Cancer, 1992, 69(2): 527-536.
- 9. 潘進(jìn)勇, 王曉維. 膀胱小細(xì)胞癌的研究進(jìn)展[J]. 中華腫瘤防治雜志, 2007, 6(14): 864-865.
- 10. Abbas F, Civantos F, Benedetto P, et al. Small cell carcinoma of the bladder and prostate[J]. Urology, 1995, 6(5): 617-630.
- 11. Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience[J]. Cancer, 2005, 103(6): 1172-1178.
- 12. Dreicer R, Manola J, Roth BJ, et al. Phase Ⅱ study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study[J]. J Clin Oncol, 2000, 18(5): 1058-1061.
- 13. Bajorin DF, McCafrey JA, Dodd PM, et al. Ifosfamide, paclitaxel, and cisplatin for patients witll advanced transitional cell carcinoma of the urothelial tract: final report of a phase Ⅱ trial evaluating two dosing schedules[J]. Cancer, 2000, 88(7): 1671-1678.
- 14. Pan CX, Yang XJ, Lopez-Behran A, et al. c-kit-Expression in small cell carcinoma of the urinary bladder: prognostic and therapo utic implications[J]. Mod Pathol, 2005, 18(3): 320-323.
- 15. 程亮, 黃文斌, 陳杰. 膀胱小細(xì)胞癌臨床病理學(xué)和分子遺傳學(xué)研究進(jìn)展[J]. 中華病理學(xué)雜志, 2007, 36(10): 700-702.